Aug 13, 2020
ViaCyte Appoints Dr. Manasi Sinha Jaiman as Vice President, Clinical Development
May 26, 2020
ViaCyte Announces $27 Million Financing to Advance Next Generation Cell Therapies for Diabetes
Feb 12, 2020
Mount Sinai Discovers New Drug Combo to Induce High Rates of Human Beta Cell Regeneration
Jul 16, 2019
IDTechEx Forecasts Changes in Century Old Paradigm for Patients With Type 1 Diabetes
Jun 19, 2019
SERAXIS Inc. inks Research Collaborative Agreement with North Carolina Research Hospital
Jun 08, 2019
Insulin-Producing Beta Cells Are Not Irreversibly Lost in Early Type 2 Diabetes
Apr 24, 2019
New PhRMA Report Shows More Than 160 Medicines in Development for Diabetes and Related Conditions
Feb 19, 2019
Diabetes Research Institute Scientists Engineer 'Suicide Genes' to Safely Grow Insulin-Producing Beta Cells from Stem Cells
Jan 21, 2019
Center for Beta Cell Therapy in Diabetes and ViaCyte Announce Start of European Clinical Trial of Human Stem Cell-derived Implants in Type 1 Diabetes Patients
Dec 20, 2018
Mount Sinai Researchers Discover New Drug Cocktail That Increases Human Beta Cell Proliferation at Rapid Rates
Nov 29, 2018
ViaCyte Secures $80 Million Financing to Advance Functional Cures for Insulin-Requiring Diabetes
Sep 05, 2018
SERAXIS Inc. announces novel method and cell line that generate highly pure populations of insulin-producing cells capable of reversing diabetes in rodents.
Jul 02, 2018
Kadimastem and The Australian Foundation for Diabetes Research (AFDR) Selected to Receive a Bi-National Grant from the Australian Government and the Israel Innovation Authority to Explore a Combined Diabetes Solution
May 02, 2018
Sigilon Therapeutics to Present at the 2nd International Pancreas and Islet Transplant Association-JDRF-Harvard Stem Cell Institute Key Opinion Leaders Meeting on Stem Cell Derived Beta Cells
Jan 19, 2018
ViaCyte to Present at Three Upcoming Healthcare Events
Dec 15, 2017
CIRM Grants ViaCyte $1.4M to Create Immune-Evasive Pluripotent Stem Cell Lines
Dec 06, 2017
ViaCyte Selected as a Winner of CONNECT's 30th Annual Most Innovative New Product Awards
Oct 04, 2017
ViaCyte to Present at Upcoming Investor and Partnering Events in October
Sep 21, 2017
ViaCyte Selected as a Finalist for CONNECT's 30th Annual Most Innovative New Product Awards
Aug 01, 2017
ViaCyte Announces First Patients Implanted with PEC-Direct Islet Cell Replacement Therapy in International Clinical Trial